Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 71 Colorectal Neoplasms 34 Rectal Neoplasms 33 Esophageal Neoplasms 25 Carcinoma, Non-Small-Cell Lung 24 Esophageal Squamous Cell Carcinoma 23 Pancreatic Neoplasms 16 Stomach Neoplasms 15 Neoplasms 15 Squamous Cell Carcinoma of Head and Neck 14 Adenocarcinoma Of Esophagus 14 Sarcoma 11 Ovarian Neoplasms 11 Lung Neoplasms 11 Colonic Neoplasms 11 Carcinoma, Hepatocellular 11 Prostatic Neoplasms 10 Head and Neck Neoplasms 10 Neoplasm Metastasis 9 Urinary Bladder Neoplasms 8 Uterine Cervical Neoplasms 7 Recurrence 6 Osteosarcoma 6 Multiple Myeloma 5 Fallopian Tube Neoplasms 5 Carcinoma, Intraductal, Noninfiltrating 5 Breast Carcinoma In Situ 5 Peritoneal Neoplasms 4 Nasopharyngeal Carcinoma 4 Locally Advanced Rectal Cancer 4

Interventions

atezolizumab 1 alectinib 1 Vemurafenib 1 Neoadjuvant Therapy 1 Fruit 1 Ado-Trastuzumab Emtansine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Genomic Instability × Neoadjuvant Therapy × Clear all

NCT06294054 2024-03-06

SELECT

University Hospital, Rouen

Urinary Bladder Neoplasms, Genomic Instability

Data powered by HemOnc (CC BY 4.0) Colophon ⚡